메뉴 건너뛰기




Volumn 21, Issue 10, 2014, Pages 980-986

Corpulence is the crucial factor: Association of testosterone and/or obesity with prostate cancer stage

Author keywords

Grade; Obesity; Overweight; Prostate cancer; Prostatectomy; Stage; Testosterone

Indexed keywords

PROSTATE SPECIFIC ANTIGEN; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE;

EID: 84908027286     PISSN: 09198172     EISSN: 14422042     Source Type: Journal    
DOI: 10.1111/iju.12494     Document Type: Article
Times cited : (11)

References (29)
  • 1
    • 84860266865 scopus 로고    scopus 로고
    • International variation in prostate cancer incidence and mortality rates
    • Center MM, Jemal A, Lortet-Tieulent J et al. International variation in prostate cancer incidence and mortality rates. Eur. Urol. 2012; 61: 1079-92.
    • (2012) Eur. Urol. , vol.61 , pp. 1079-1092
    • Center, M.M.1    Jemal, A.2    Lortet-Tieulent, J.3
  • 2
    • 84856235306 scopus 로고    scopus 로고
    • Cruciferous vegetables intake and risk of prostate cancer: a meta-analysis
    • Liu B, Mao Q, Cao M, Xie L. Cruciferous vegetables intake and risk of prostate cancer: a meta-analysis. Int. J. Urol. 2012; 19: 134-41.
    • (2012) Int. J. Urol. , vol.19 , pp. 134-141
    • Liu, B.1    Mao, Q.2    Cao, M.3    Xie, L.4
  • 3
    • 0037464510 scopus 로고    scopus 로고
    • Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults
    • Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N. Engl. J. Med. 2003; 348: 1625-38.
    • (2003) N. Engl. J. Med. , vol.348 , pp. 1625-1638
    • Calle, E.E.1    Rodriguez, C.2    Walker-Thurmond, K.3    Thun, M.J.4
  • 5
    • 79955872008 scopus 로고    scopus 로고
    • Body mass index, prostate cancer-specific mortality, and biochemical recurrence: a systematic review and meta-analysis
    • Cao Y, Ma J. Body mass index, prostate cancer-specific mortality, and biochemical recurrence: a systematic review and meta-analysis. Cancer Prev. Res. 2011; 4: 486-501.
    • (2011) Cancer Prev. Res. , vol.4 , pp. 486-501
    • Cao, Y.1    Ma, J.2
  • 6
    • 33947202141 scopus 로고    scopus 로고
    • Obesity is associated with increased risks of prostate cancer metastasis and death after initial cancer diagnosis in middle-aged men
    • Gong Z, Agalliu I, Lin DW, Stanford JL, Kristal AR. Obesity is associated with increased risks of prostate cancer metastasis and death after initial cancer diagnosis in middle-aged men. Cancer 2007; 109: 1192-202.
    • (2007) Cancer , vol.109 , pp. 1192-1202
    • Gong, Z.1    Agalliu, I.2    Lin, D.W.3    Stanford, J.L.4    Kristal, A.R.5
  • 7
    • 0035313592 scopus 로고    scopus 로고
    • High-grade prostate cancer is associated with low serum testosterone levels
    • Schatzl G, Madersbacher S, Thurridl T et al. High-grade prostate cancer is associated with low serum testosterone levels. Prostate 2001; 47: 52-8.
    • (2001) Prostate , vol.47 , pp. 52-58
    • Schatzl, G.1    Madersbacher, S.2    Thurridl, T.3
  • 8
    • 0344406150 scopus 로고    scopus 로고
    • Pretreatment total testosterone level predicts pathological stage in patients with localized prostate cancer treated with radical prostatectomy
    • Massengill JC, Sun L, Moul JW et al. Pretreatment total testosterone level predicts pathological stage in patients with localized prostate cancer treated with radical prostatectomy. J. Urol. 2003; 169: 1670-5.
    • (2003) J. Urol. , vol.169 , pp. 1670-1675
    • Massengill, J.C.1    Sun, L.2    Moul, J.W.3
  • 9
    • 84876437430 scopus 로고    scopus 로고
    • Circulating free testosterone is an independent predictor of advanced disease in patients with clinically localized prostate cancer
    • Schnoeller T, Jentzmik F, Rinnab L et al. Circulating free testosterone is an independent predictor of advanced disease in patients with clinically localized prostate cancer. World J. Urol. 2013; 31: 253-9.
    • (2013) World J. Urol. , vol.31 , pp. 253-259
    • Schnoeller, T.1    Jentzmik, F.2    Rinnab, L.3
  • 10
    • 0033305020 scopus 로고    scopus 로고
    • A critical evaluation of simple methods for the estimation of free testosterone in serum
    • Vermeulen A, Verdonck L, Kaufman JM. A critical evaluation of simple methods for the estimation of free testosterone in serum. J. Clin. Endocrinol. Metab. 1999; 84: 3666-72.
    • (1999) J. Clin. Endocrinol. Metab. , vol.84 , pp. 3666-3672
    • Vermeulen, A.1    Verdonck, L.2    Kaufman, J.M.3
  • 11
    • 0034471041 scopus 로고    scopus 로고
    • Obesity: preventing and managing the global epidemic. Report of a WHO consultation
    • Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ. Tech. Rep. Ser. 2000; 894: 1-7.
    • (2000) World Health Organ. Tech. Rep. Ser , vol.894 , pp. 1-7
  • 12
    • 0030690915 scopus 로고    scopus 로고
    • Low serum testosterone and a younger age predict for a poor outcome in metastatic prostate cancer
    • Ribeiro M, Ruff P, Falkson G. Low serum testosterone and a younger age predict for a poor outcome in metastatic prostate cancer. Am. J. Clin. Oncol. 1997; 20: 605-8.
    • (1997) Am. J. Clin. Oncol. , vol.20 , pp. 605-608
    • Ribeiro, M.1    Ruff, P.2    Falkson, G.3
  • 13
    • 33748120911 scopus 로고    scopus 로고
    • Association between the dihydrotestosterone level in the prostate and prostate cancer aggressiveness using the Gleason score
    • Nishiyama T, Ikarashi T, Hashimoto Y, Suzuki K, Takahashi K. Association between the dihydrotestosterone level in the prostate and prostate cancer aggressiveness using the Gleason score. J. Urol. 2006; 176: 1387-91.
    • (2006) J. Urol. , vol.176 , pp. 1387-1391
    • Nishiyama, T.1    Ikarashi, T.2    Hashimoto, Y.3    Suzuki, K.4    Takahashi, K.5
  • 14
    • 35148851505 scopus 로고    scopus 로고
    • Prolonged exposure to reduced levels of androgen accelerates prostate cancer progression in Nkx3.1; Pten mutant mice
    • Banach-Petrosky W, Jessen WJ, Ouyang X et al. Prolonged exposure to reduced levels of androgen accelerates prostate cancer progression in Nkx3.1; Pten mutant mice. Cancer Res. 2007; 67: 9089-96.
    • (2007) Cancer Res. , vol.67 , pp. 9089-9096
    • Banach-Petrosky, W.1    Jessen, W.J.2    Ouyang, X.3
  • 15
    • 0037377311 scopus 로고    scopus 로고
    • Associations of serum testosterone with microvessel density, androgen receptor density and androgen receptor gene polymorphism in prostate cancer
    • Schatzl G, Madersbacher S, Haitel A et al. Associations of serum testosterone with microvessel density, androgen receptor density and androgen receptor gene polymorphism in prostate cancer. J. Urol. 2003; 169: 1312-15.
    • (2003) J. Urol. , vol.169 , pp. 1312-1315
    • Schatzl, G.1    Madersbacher, S.2    Haitel, A.3
  • 16
    • 0037812658 scopus 로고    scopus 로고
    • The influence of finasteride on the development of prostate cancer
    • Thompson IM, Goodman PJ, Tangen CM et al. The influence of finasteride on the development of prostate cancer. N. Engl. J. Med. 2003; 349: 215-24.
    • (2003) N. Engl. J. Med. , vol.349 , pp. 215-224
    • Thompson, I.M.1    Goodman, P.J.2    Tangen, C.M.3
  • 17
    • 84908021388 scopus 로고    scopus 로고
    • The Association between Finasteride use and High-grade or Lethal Prostate Cancer
    • Preston MA, Wilson K, Coseo-Markt S et al. The Association between Finasteride use and High-grade or Lethal Prostate Cancer. J. Urol. 2013; 189: e94 (Abstract 228).
    • (2013) J. Urol , vol.189 , pp. e94
    • Preston, M.A.1    Wilson, K.2    Coseo-Markt, S.3
  • 18
    • 84908031814 scopus 로고    scopus 로고
    • 5 a reductase inhibitors and risk of prostate cancer. Nation-wide, population-based case-control study
    • Robinson D, Garmo H, Bill-Axelson A, Lorelei L, Holmberg L, Stattin P. 5 a reductase inhibitors and risk of prostate cancer. Nation-wide, population-based case-control study. J. Urol. 2013; 189: e795-6 (abstract 1941).
    • (2013) J. Urol , vol.189 , pp. e795-e796
    • Robinson, D.1    Garmo, H.2    Bill-Axelson, A.3    Lorelei, L.4    Holmberg, L.5    Stattin, P.6
  • 19
    • 84887609075 scopus 로고    scopus 로고
    • Obese men have more advanced and more aggressive prostate cancer at time of surgery than non-obese men after adjusting for screening PSA level and age: results from two independent nested case-control studies
    • Parker AS, Thiel DD, Bergstralh E et al. Obese men have more advanced and more aggressive prostate cancer at time of surgery than non-obese men after adjusting for screening PSA level and age: results from two independent nested case-control studies. Prostate Cancer Prostatic Dis. 2013; 20: 352-6.
    • (2013) Prostate Cancer Prostatic Dis. , vol.20 , pp. 352-356
    • Parker, A.S.1    Thiel, D.D.2    Bergstralh, E.3
  • 20
    • 62149129232 scopus 로고    scopus 로고
    • Is the body mass index a predictor of adverse outcome in prostate cancer after radical prostatectomy in a mid-European study population?
    • Pfitzenmaier J, Pritsch M, Haferkamp A et al. Is the body mass index a predictor of adverse outcome in prostate cancer after radical prostatectomy in a mid-European study population? BJU Int. 2009; 103: 877-82.
    • (2009) BJU Int. , vol.103 , pp. 877-882
    • Pfitzenmaier, J.1    Pritsch, M.2    Haferkamp, A.3
  • 21
    • 34547136177 scopus 로고    scopus 로고
    • Obesity does not predispose to more aggressive prostate cancer either at biopsy or radical prostatectomy in European men
    • Gallina A, Karakiewicz PI, Hutterer GC et al. Obesity does not predispose to more aggressive prostate cancer either at biopsy or radical prostatectomy in European men. Int. J. Cancer 2007; 121: 791-5.
    • (2007) Int. J. Cancer , vol.121 , pp. 791-795
    • Gallina, A.1    Karakiewicz, P.I.2    Hutterer, G.C.3
  • 22
    • 80053637321 scopus 로고    scopus 로고
    • Body mass index is not a predictor of biochemical recurrence after radical prostatectomy in Dutch men diagnosed with prostate cancer
    • Kok DE, van Roermund JG, Aben KK et al. Body mass index is not a predictor of biochemical recurrence after radical prostatectomy in Dutch men diagnosed with prostate cancer. World J. Urol. 2011; 29: 695-701.
    • (2011) World J. Urol. , vol.29 , pp. 695-701
    • Kok, D.E.1    van Roermund, J.G.2    Aben, K.K.3
  • 24
    • 84876059411 scopus 로고    scopus 로고
    • Obesity and prostate cancer: weighing the evidence
    • Allott EH, Masko EM, Freedland SJ. Obesity and prostate cancer: weighing the evidence. Eur. Urol. 2013; 63: 800-9.
    • (2013) Eur. Urol. , vol.63 , pp. 800-809
    • Allott, E.H.1    Masko, E.M.2    Freedland, S.J.3
  • 25
    • 84876514140 scopus 로고    scopus 로고
    • New players for advanced prostate cancer and the rationalisation of insulin-sensitising medication
    • Gunter JH, Sarkar PL, Lubik AA, Nelson CC. New players for advanced prostate cancer and the rationalisation of insulin-sensitising medication. Int. J. Cell Biol. 2013; 2013: 834684.
    • (2013) Int. J. Cell Biol. , vol.2013 , pp. 834684
    • Gunter, J.H.1    Sarkar, P.L.2    Lubik, A.A.3    Nelson, C.C.4
  • 26
    • 36348982774 scopus 로고    scopus 로고
    • Obesity-related plasma hemodilution and PSA concentration among men with prostate cancer
    • Banez LL, Hamilton RJ, Partin AW et al. Obesity-related plasma hemodilution and PSA concentration among men with prostate cancer. JAMA 2007; 298: 2275-80.
    • (2007) JAMA , vol.298 , pp. 2275-2280
    • Banez, L.L.1    Hamilton, R.J.2    Partin, A.W.3
  • 27
    • 64549162443 scopus 로고    scopus 로고
    • Serum prostate-specific antigen hemodilution among obese men undergoing screening in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
    • Grubb RL III, Black A, Izmirlian G et al. Serum prostate-specific antigen hemodilution among obese men undergoing screening in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Cancer Epidemiol. Biomarkers Prev. 2009; 18: 748-51.
    • (2009) Cancer Epidemiol. Biomarkers Prev. , vol.18 , pp. 748-751
    • Grubb III, R.L.1    Black, A.2    Izmirlian, G.3
  • 28
    • 84880774348 scopus 로고    scopus 로고
    • Does obesity affect the accuracy of prostate-specific antigen (PSA) for predicting prostate cancer among men undergoing prostate biopsy
    • Oh JJ, Jeong SJ, Lee BK et al. Does obesity affect the accuracy of prostate-specific antigen (PSA) for predicting prostate cancer among men undergoing prostate biopsy. BJU Int. 2013; 112: E265-71. doi: 10.1111/j.464-410X.2012.11766.x
    • (2013) BJU Int , vol.112 , pp. E265-E271
    • Oh, J.J.1    Jeong, S.J.2    Lee, B.K.3
  • 29
    • 77957220643 scopus 로고    scopus 로고
    • A higher prediagnostic insulin level is a prospective risk factor for incident prostate cancer
    • Hammarsten J, Damber JE, Peeker R, Mellstrom D, Hogstedt B. A higher prediagnostic insulin level is a prospective risk factor for incident prostate cancer. Cancer Epidemiol. 2010; 34: 574-9.
    • (2010) Cancer Epidemiol. , vol.34 , pp. 574-579
    • Hammarsten, J.1    Damber, J.E.2    Peeker, R.3    Mellstrom, D.4    Hogstedt, B.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.